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Incomplete CD8
 
1
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as a Mechanism for Subdominant Cytotoxic 
T Lymphocyte Responses to a Viral Antigen
 
By Juliet V. Spencer
 
 
 
and Thomas J. Braciale
 
From the Beirne B. Carter Center for Immunology Research, University of Virginia, Charlottesville, 
Virginia 22906
 
Abstract
 
CD8
 
1
 
 cytotoxic T lymphocytes (CTLs) recognize antigen in the context of major histocom-
patibility complex (MHC) class I molecules. Class I epitopes have been classified as dominant
or subdominant depending on the magnitude of the CTL response to the epitope. In this re-
 
port, we have examined the in vitro memory CTL response of H-2
 
d
 
 haplotype murine CD8
 
1
 
T lymphocytes specific for a dominant and subdominant epitope of influenza hemagglutinin
using activation marker expression and staining with soluble tetrameric MHC–peptide com-
plexes. Immune CD8
 
1
 
 T lymphocytes specific for the dominant HA204-210 epitope give rise
to CTL effectors that display activation markers, stain with the HA204 tetramer, and exhibit
effector functions (i.e., cytolytic activity and cytokine synthesis). In contrast, stimulation of
memory CD8
 
1
 
 T lymphocytes directed to the subdominant HA210-219 epitope results in the
generation of a large population of activated CD8
 
1
 
 T cells that exhibit weak cytolytic activity
and fail to stain with the HA210 tetramer. After additional rounds of restimulation with anti-
gen, the HA210-219–specific subdominant CD8
 
1
 
 T lymphocytes give rise to daughter cells
that acquire antigen-specific CTL effector activity and transition from a HA210 tetramer–neg-
ative to a tetramer-positive phenotype. These results suggest a novel mechanism to account for
weak CD8
 
1
 
 CTL responses to subdominant epitopes at the level of CD8
 
1
 
 T lymphocyte dif-
ferentiation into effector CTL. The implications of these findings for CD8
 
1
 
 T lymphocyte ac-
tivation are discussed.
Key words: immunodominance • MHC class I tetramer • CD8
 
1
 
 T cell • anergy • self-peptide
 
Introduction
 
The cell-mediated immune response is critical for the
clearance of viral pathogens (1). In particular, CD8
 
1
 
 CTLs
have been demonstrated to be effective in the elimination
of several different viruses, including influenza (2–4) and
lymphocytic choriomeningitis virus (LCMV)
 
1 
 
(5–7). CTLs
recognize peptide antigens, derived from intracellular pro-
cessing of proteins, complexed with MHC class I molecules
on the cell surface (8). Although most pathogens are com-
posed of numerous foreign proteins, the T cell response is
often directed at only a limited number of peptide epitopes
(9, 10). The magnitude of the response to these determi-
 
nants is variable: some epitopes elicit a strong or immu-
nodominant response, whereas others generate only a weak
or subdominant response, and still others are described as
cryptic, eliciting little if any detectable immune response
(11). The factors regulating immunodominance have not
been clearly defined, although the complex mechanisms of
antigen processing and presentation, T cell priming and ex-
pansion, as well as limitations in the T cell repertoire are
likely to play some role (12).
The CD8
 
1
 
 T cell response to influenza virus infection
has been well characterized in several laboratories (13).
Three epitopes recognized by murine CTLs in association
with K
 
d
 
 molecules in H-2
 
d
 
 mice have been identified in
the influenza hemagglutinin (HA [14, 15]). Two of these
epitopes are partially overlapping, spanning the residues
HA204-212 and HA210-219, whereas the third, HA529-
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Abbreviations used in this paper: 
 
AA, A/Ann Arbor/57 influenza virus
strain; GV, A/Guiyang/57-variant 17 influenza virus strain; HA, influenza
 
hemagglutinin; HA A
 
2
 
, truncated A/Japan/57 HA; JAK, Janus kinase;
LCMV, lymphocytic choriomeningitis virus; LDA, limiting dilution assay;
pCTL, precursor CTL; rVV HA A
 
2
 
, recombinant vaccinia virus express-
ing the A/Japan/305/57 HA protein lacking the transmembrane region.
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537, is derived from the transmembrane domain of the HA
molecule.
The two overlapping epitopes, HA204-212 and HA210-
219, are of particular interest because they differ markedly
in immunogenicity. The HA204-212 epitope, like the
HA529-537 epitope, is immunodominant and elicits a ro-
bust in vitro secondary CTL response in immune BALB/c
mice in response to infectious A/Japan/57 influenza virus
(14, 16). In comparison, the in vitro secondary CTL re-
sponse to the HA210-219 epitope is weak and variable
(17). Previous studies suggested that the efficiency of anti-
gen processing and peptide transport cannot account for
the difference in immunogenicity of the two epitopes (18).
It was also shown that the HA204-212 and HA210-219
peptides were equally efficient at stabilizing cell surface ex-
pression of K
 
d
 
 molecules on transfected RMA-S cells, indi-
cating that inefficient binding of the HA210-219 peptide to
K
 
d
 
 molecules was not the underlying cause for the weak re-
sponse to this epitope (19). However, additional work us-
ing the limiting dilution assay (LDA) to quantitate the
number of precursor CTLs (pCTLs) specific for each
epitope demonstrated a 10–20-fold lower frequency of
HA210-219–specific pCTLs compared with HA204-212–
specific pCTLs, suggesting that the subdominant response
to the HA210-219 epitope is a reflection of a limited num-
ber of HA210-219 pCTLs in the T cell pool (17).
Although the LDA has been widely used to quantitate
relative numbers of effector T cells, recent technological
advances have provided tools for direct staining of anti-
gen-specific cells without relying on effector readouts
(20). Virus-specific CTLs have been detected by staining
with tetrameric MHC class I–peptide complexes in re-
sponse to HIV (20), simian immunodeficiency virus (21),
EBV (22), LCMV (23), and influenza (24). Reevaluation
of the immune response to acute LCMV infection using
tetramer staining has demonstrated that massive expansion
of the CD8
 
1
 
 T cell population is almost entirely due to vi-
rus-specific CTL, and that previous reports had thus un-
derestimated the antigen-specific response as measured by
LDA (25).
In light of these observations, we have reexamined the
magnitude of the memory CTL response to the HA204-
212 and HA210-219 epitopes using activation marker ex-
pression and MHC class I–peptide tetramer staining. After
in vitro stimulation of immune pCTLs with virus, we de-
tected high levels of antigen-specific cytolytic activity and
higher percentages of tetramer-positive, IFN-
 
g
 
–producing
CD8
 
1
 
 T cells responding to the dominant HA204-214
epitope than to the subdominant HA210-219 epitope. This
result is consistent with our previous observations on the
subdominance of the response to the HA210-219 epitope.
Despite the low level of specific cytolytic activity and the
low percentage of cells staining with HA210 tetramer, cul-
tures responding to the subdominant epitope had a high
percentage of CD8
 
1
 
 lymphoblasts displaying markers of ac-
tivated T cells. To evaluate the antigen specificity of the ac-
tivated CD8
 
1
 
 cells responding to the subdominant epitope,
and to further characterize these cells, we subjected the cul-
 
tures to two successive rounds of restimulation with anti-
gen. We found that there was selective expansion and en-
richment of both HA210 tetramer–positive and –negative
CD8
 
1
 
 T lymphocytes in response to the subdominant
HA210-219 epitope, with HA210 tetramer–positive cells
representing an increasing percentage of the total CD8
 
1
 
cells over successive stimulations. After restimulation, the
subdominant CD8
 
1
 
 blast cells acquired antigen-specific cy-
tolytic activity and the ability to secrete IFN-
 
g
 
. This CTL
effector activity was exhibited by both HA210 tetramer–
positive and –negative CD8
 
1
 
 T lymphocyte populations.
We further demonstrated that tetramer-negative HA210-
219–specific CD8
 
1
 
 cells give rise to HA210 tetramer–posi-
tive cells in response to antigenic stimulation. These results
suggest a novel mechanism for an apparently weak or sub-
dominant CD8
 
1
 
 T lymphocyte response to viral antigen
where specific CTL precursors are present at high fre-
quency and activate in response to initial antigen stimula-
tion, but do not fully differentiate into effector CTLs.
 
Materials and Methods
 
Mice. 
 
6-wk-old female BALB/cAnNTac (H-2
 
d
 
) mice were
purchased from Taconic Farms.
 
Viruses. 
 
Influenza virus strains A/Ann Arbor/57 (AA), A/Gui-
yang/57-variant 17 (GV), and B/Lee were grown in the allan-
toic cavity of 10-d-old chicken embryos and stored as infec-
tious allantoic fluid at 
 
2
 
70
 
8
 
C (26). Recombinant vaccinia viruses
expressing the A/Japan/305/57 HA protein lacking the trans-
membrane region (rVV HA A
 
2
 
) were prepared from monolayer
cultures of BSC-40 cells as described (27).
 
Cell Lines. 
 
The P815 (H-2
 
d
 
) mastocytoma cell line was
maintained in DMEM (Life Technologies) supplemented with
10% FCS and 1% glutamine. CTL clones E2 and D4 were iso-
lated pCTLs primed with influenza A/Japan/305/57 virus and es-
tablished as described previously (27a). Cloned CTL lines were
stimulated weekly with irradiated BALB/c splenocytes infected
with influenza virus and human rIL-2 (10 U/ml).
 
Bulk CTL Populations. 
 
Mice were primed intraperitoneally
with 10
 
7
 
 units of infectious rVV HA A
 
2
 
 virus. 3 wk later, spleno-
cytes were removed and restimulated in vitro with irradiated in-
fluenza virus–infected splenocytes. Subsequent in vitro stimula-
tions were performed as above with the addition of rIL-2 (10 U/ml)
to the medium.
 
Peptides. 
 
Synthetic oligopeptides were produced on an auto-
mated Solid Phase Peptides Synthesizer (PE Biosystems). HPLC
analysis showed that peptide preparations were 
 
.
 
95% pure. Stock
solutions of synthetic peptides were dissolved in 100% DMSO at
concentrations of 5 mg/ml and diluted to the desired concentra-
tions immediately before use in in vitro stimulations or cytotoxic-
ity assays.
 
CTL-mediated Cytotoxicity Assays. 
 
P815 cells were used as
target cells in a sodium chromate (
 
51
 
Cr)-release assay as described
previously(14). In brief, 
 
51
 
Cr-labeled target cells were washed
twice and plated in 96-well microtiter plates at 10
 
4
 
 per well in 0.1
ml assay medium. Peptide solutions or medium were added to
each well in a 0.05-ml volume. Finally, T cells from day 5 bulk
cultures were added in a volume of 0.05 ml per well. After incu-
bation for 5 h at 37
 
8
 
C, 0.1 ml culture supernatant from each well
was removed and counted for radioactivity. Values for percentage
of specific release were calculated as described (14).
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MHC Class I–Peptide Tetramers. 
 
MHC class I–peptide tet-
ramers were produced as described by Altman et al. (20). Plasmid
DNA encoding the extracellular domain of the H2-K
 
d
 
 heavy
chain and human 
 
b
 
2
 
-microglobulin were provided Eric Pamer
(Yale University, New Haven, CT). Recombinant proteins were
expressed in 
 
Escherichia coli
 
, purified from inclusion bodies, solubi-
lized, and refolded in the presence of A/Japan/305/57 influenza
HA epitopes (204-212 or JHA210-219) or an H2-K
 
d
 
–restricted
Janus kinase (JAK)-1–derived self-peptide, as described (28). Folded
complexes consisting of H2-K
 
d
 
, 
 
b
 
2
 
-microglobulin, and antigenic
peptide were purified by gel filtration over a Superdex 200 HR
column (Amersham Pharmacia Biotech), then enzymatically bi-
otinylated with the biotin–protein ligase BirA (Avidity) and tet-
ramerized with PE-labeled streptavidin (Molecular Probes). Tetra-
mers were stored at 5 mg/ml at 4
 
8
 
C in PBS (pH 8.0) containing
0.02% sodium azide, 1 
 
m
 
g/ml pepstatin, 1 
 
m
 
g/ml leupeptin, and
0.5 mM EDTA.
 
Cell Staining and Flow Cytometry. 
 
T lymphocytes were iso-
lated from a centrifuged Ficoll-Hypaque (Fico-Lite; Atlanta Bio-
logicals) gradient of the bulk splenocyte cultures and stained at
4
 
8
 
C for 1 h. Tetrameric H2-K
 
d
 
–peptide complexes or the fol-
lowing fluorochrome-conjugated antibodies (BD PharMingen)
were used: anti-CD8
 
a
 
–CyChrome or –perCP (53-6.7), anti-
TCR V
 
b
 
–FITC, anti-CD62L–FITC (MEL-14), and anti-CD44–
FITC. After washing, the cells were fixed in 1% paraformalde-
hyde, then analyzed on a FACSCalibur™ (Becton Dickinson)
using CELLQuest™ software. In some experiments, tetramer
staining was carried out at 37
 
8
 
C with identical results.
Cell proliferation was assayed by labeling with carboxyfluores-
cein succinimidyl diacetate ester (CFSE; Molecular Probes) as de-
scribed (29). Resting lymphocytes were incubated with 1.8 
 
m
 
M
CFSE in PBS (pH 7.4) at room temperature for 7 min, washed
twice, and then restimulated with virus-infected APCs as above.
Cells were examined 4–5 d after stimulation by flow cytometry
for evidence proliferation, as indicated by loss of CFSE intensity.
For cell sorting, cells were stained as above and a sterile sort
was performed at the University of Virginia FACS
 
®
 
 Core Facility
using a FACS Vantage™ cell sorter (Becton Dickinson). Sorted
populations were examined for purity and then either restimu-
lated or used in cytolysis assays. Alternatively, cells were separated
by MACS (Miltenyi Biotec) after staining with tetramer–PE and
anti-PE microbeads. For both FACS
 
®
 
 and MACS separations,
cell populations were observed to be 
 
.
 
99% pure.
 
Intracellular Cytokine Staining. 
 
T lymphocytes from bulk cul-
tures were incubated with peptide-pulsed P815 target cells (E/T
 
 5
 
1:2) for 5 h in the presence of 10 U/ml IL-2 and 2 
 
m
 
M monen-
sin. After staining for extracellular markers, cells were permeabi-
lized with 0.5% saponin, stained with antibodies to IFN-
 
g
 
–FITC
(BD PharMingen), and examined by flow cytometry as above.
 
Results
 
The CD8
 
1
 
 T cell response to the A/Japan/57 HA in
H2
 
d
 
 haplotype BALB/c mice is directed to three H2-K
 
d
 
–
restricted epitopes (15). Two of these epitopes, HA204-
212 and HA529-537, elicit vigorous memory CD8
 
1
 
 CTL
responses and are classified as dominant. The third epitope,
HA210-219, is subdominant and elicits a weak, variable CTL
response after priming and in vitro challenge with A/Japan/
57 virus (17). The weak response to HA210-219 is not due
to inefficient processing or presentation of the epitope (30),
 
and was attributed to an apparent low frequency of CD8
 
1
 
memory T cells directed to this site (17). As the designation
of HA-specific CD8
 
1
 
 CTL epitopes as dominant or sub-
dominant was based on the in vitro lytic activity of CTL
effectors, we wanted to directly evaluate the number of
memory CTL effectors directed to the subdominant
HA210-219 epitope and a dominant epitope, HA 204-212,
by MHC class I tetramer staining. Tetramers were prepared
that consisted of the H2-K
 
d
 
 molecules loaded with the
HA204-212 peptide (HA204 tetramer) or the HA210-219
peptide (HA210 tetramer), respectively. The specificity of
binding of these HA tetramers was established by flow cy-
tometry using clonal populations of HA204-212–specific
and HA219-219–specific CTLs. As Fig. 1 demonstrates,
HA204 tetramers selectively stained the HA204-212–spe-
cific CTL clone E2 (Fig. 1 A), whereas the HA210 tetra-
mers selectively bound the HA210-219–specific CTL clone
D4 (Fig. 1 B). Comparable specificity of tetramer staining
was obtained with other HA-specific CD8
 
1
 
 CTL clones.
Neither CTL clone bound a control tetramer containing a
K
 
d
 
-binding self-peptide derived from the murine JAK-1
kinase, further establishing the specificity of tetramer
staining.
As noted above, infection with the A/Japan/57 virus
stimulates K
 
d
 
-restricted responses to three HA epitopes and
to a dominant site on the influenza nucleoprotein (NP
147–155). Because antigenic competition has been sug-
gested to influence the magnitude of CD8
 
1
 
 CTL responses
to specific epitopes (31, 32), we wanted to quantitate the
memory CTL response to the dominant and subdominant
HA CTL epitopes independently while still using a physi-
ological stimulus (i.e., infectious virus) as the recall stimu-
lus. To avoid the simultaneous induction of a primary
CD8
 
1
 
 CTL response during infection in vivo
 
,
 
 the mem-
ory CTL response was analyzed in vitro. To do so, we
used the following priming and recall strategy. BALB/c
Figure 1. Specificity of tet-
ramer staining on cloned CTL
lines. (A) Staining of HA204-
specific cloned CTL line E2 with
a panel of tetramer reagents. (B)
Staining of HA210-specific cloned
CTL cell line D4 with the same
panel of reagents. Unstained cells
(dashed line), Kd–HA204 tetra-
mer (broken line), Kd–HA210
tetramer (solid line), Kd–JAK-1
tetramer (dotted line).
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mice were primed with a recombinant vaccinia virus ex-
pressing a truncated A/Japan/57 HA (HA A
 
2
 
) lacking the
transmembrane domain and cytoplasmic tail of the HA
gene product. This mutant HA lacks the dominant
HA529-537 transmembrane epitope, but it does express
the dominant HA204-212 and the subdominant HA210-
219 epitopes. Therefore, this vaccination strategy should
prime memory CD8
 
1
 
 T lymphocytes directed only to the
HA204-212 and HA210-219 epitopes. Since in vitro re-
stimulation of immune cells with infectious influenza virus
preferentially activates memory CD8
 
1
 
 T lymphocytes, ir-
radiated splenocyte APCs infected with either the AA or
the GV influenza strain were used to reactivate A/Japan/
57–specific memory CD8
 
1
 
 T lymphocytes directed to the
HA204-212 or HA210-219 epitopes, respectively. The
HA proteins of these two H2N2 influenza strains are sero-
logically and structurally closely related to the A/Japan/57
HA, but they differ slightly in amino acid sequence from
the A/Japan/57 HA.
 
 
 
The AA HA is identical to the A/Ja-
pan/57 HA at 204–212, but the sequence differs at one
residue in the HA210-219 epitope. This glycine to serine
change at position 215 results in an epitope that is not rec-
ognized by A/Japan/57 HA210-219–specific CTLs (15).
Likewise, the GV HA retains the HA210-219 epitope of
the A/Japan/57 HA but has a single amino acid substitu-
tion at position 207 (N207K) in the HA204-212 epitope,
which is not recognized by A/Japan/57 HA204-212–spe-
cific CTLs.
 
Immune splenocytes from two or three HA A
 
2
 
–primed
donors were pooled and restimulated in vitro
 
 
 
with irradi-
ated splenocyte APCs infected with either the AA virus,
the GV virus, or the unrelated type B influenza strain LEE.
5 d after in vitro restimulation, cultures were examined for
HA tetramer staining and cell surface expression of the acti-
vation-associated markers CD62L and CD44, as well as for
cytolytic activity and IFN-
 
g
 
 production. Representative
results from these experiments are shown in Figs. 2 and 3
and in Table I. CD8
 
1
 
 T cells that stained positive with the
HA204 tetramer were readily demonstrated in cultures
stimulated with the AA virus, and 15.6% of total CD8
 
1
 
 T
cells were observed to bind tetramer in the representative
experiment shown (Fig. 2 A). In addition to HA204 tet-
ramer staining, stimulation of memory CD8
 
1
 
 T cells with
the AA virus was associated with a vigorous cytolytic re-
sponse directed toward HA204-212 peptide–pulsed targets
(Fig. 3 A). These cytolytic effectors did not lyse target cells
pulsed with the HA210-219 or HA529-537 peptide, sug-
gesting that stimulation of immune cells with the AA virus
had selectively activated HA204-212–specific memory
CD8
 
1
 
 T lymphocytes. The strong cytolytic response to the
dominant HA204-212 epitope is consistent with our earlier
observations using A/Japan/57 virus for priming and in
vitro reactivation of memory CTL effectors directed to this
epitope (17). Analysis of the fraction of CD8
 
1
 
 T lympho-
cytes staining for IFN-
 
g 
 
production (12%; Fig. 3 C) and for
the CD62L
 
lo
 
CD44
 
hi 
 
phenotype (18.3%; Table I) demon-
Figure 2. Activation of HA-specific memory CTLs. BALB/c mice
were immunized with a recombinant vaccinia virus expressing a trun-
cated version of the HA protein. 3 wk later, immune splenocytes were
stimulated in vitro with APCs infected with (A and B) AA virus (for
HA204-212 responses) or (C and D) GV virus (for HA210-219 re-
sponses). 5 d after in vitro stimulation, cells were harvested and stained
with anti-CD8–CyChrome and the Kd–JAK-1 or indicated HA tetramer,
then analyzed by flow cytometry. Numbers in the corner of the upper
right quadrant represent the percentage of total CD81 T cells that stained
positive with HA tetramer. These results are representative of five inde-
pendent experiments.
Figure 3. Effector activity of
bulk cultures. Cytolytic activity
and cytokine production by HA-
specific CTLs was measured on
day 5 after in vitro stimulation.
For cytolysis assays, bulk immune
cell populations were incubated
with 51Cr-labeled P815 target cells
pulsed with 1029 M concentration
of the indicated peptide over a
range of E/T ratios for 5 h at
378C. (A) AA-stimulated cultures
(HA204 enriched). (B) GV-stim-
ulated cultures (HA210 enriched).
Intracellular cytokine staining was
performed by incubating day 5
cells with 1026 M HA204-212 or
HA210-219 peptide–pulsed P815
target cells (E/T 5 1:2) in the
presence of IL-2 and monensin
for 6 h at 378C. Cells were stained
with anti-CD8–CyChrome, then
permeabilized and stained with
anti–FITC-conjugated IFN-g or
isotype control antibody (not
shown). Histogram values are the
average percentage of IFN-g–
secreting CD81 T cells in re-
sponse to peptide from duplicate
cultures. (C) AA-stimulated cul-
tures (HA204 enriched). (D) GV-
stimulated cultures (HA210 en-
riched).
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strated a good correlation with the percentage of HA204-
212–specific CTLs estimated by tetramer staining (15.6%;
Fig. 2 A).
Analysis of the frequency of subdominant HA210-219–
specific CTL effectors elicited by stimulation with the GV
virus was carried out in parallel using the same pool of im-
mune splenocytes. In the representative experiment shown
(Fig. 2 C), only 6.1% of CD81 T cells were HA210 tet-
ramer positive in the GV-stimulated culture. The lower
percentage of HA210-staining CD81 T cells directed to
the subdominant epitope was associated with a weak cy-
tolytic response that was specific for the HA210-219
epitope (Fig. 3 B). Consistent with our earlier observations,
the cytolytic response to the HA210-219 epitope was at
least 10-fold lower in cytolytic activity than the response to
the dominant HA204-212 epitope (17). In keeping with the
low percentage of HA210 tetramer binding cells and the
weak cytolytic response, GV virus–stimulated cultures had
a low frequency of CD81 T lymphocytes that produced
IFN-g in response to the HA210-219 peptide (4.3%; Fig. 3
D). However, cultures of immune cells stimulated with the
GV virus appeared highly activated by visual inspection.
When these cultures were examined for expression of
CD62L and CD44, 25.2% of CD81 T cells in the GV-
stimulated cultures exhibited an activated phenotype
(CD62LloCD44hi), as shown in Table I. The percentage of
CD81 T cells with an activated phenotype was consistently
higher in the subdominant cultures than in the dominant
HA204-212 cultures (Table I).
This high percentage of activated CD81 T cells in GV-
stimulated cultures was not readily attributable to exposure
of CD81 T cells to virus-infected APCs, as companion cul-
tures of HA A2 immune splenocytes exposed to the unre-
lated influenza B/Lee virus exhibited only minimal CD81
T cell activation (Table I). Identical results were obtained
when cytolytic activity was examined at days 6–10 after
stimulation (data not shown), which implies that the ab-
sence of effector activity in these highly activated HA210-
219–specific cultures was not due to delayed kinetics of the
expression of effector activity. To determine if the genera-
tion of activated noncytolytic CD81 T lymphocytes in re-
sponse to the subdominant HA210-219 epitope was due to
an unrelated property of the GV virus, the responses of im-
mune splenocytes to GV-infected APCs and APCs pulsed
with the synthetic HA210-219 peptide were compared. As
Table II demonstrates, peptide-stimulated cultures con-
tained an even higher percentage of activated CD81 T cells
than virus-stimulated cultures at day 5–6 after stimulation;
however, like the GV virus–stimulated culture, these acti-
vated CD81 T cells exhibited minimal cytolytic activity on
HA210-219–expressing target cells. These results raised the
possibility that HA210-219–specific memory CD81 T cells
are present at a high frequency in immune animals and are
capable of responding to the subdominant HA210-219
epitope. However, the responding CD81 T cell population
fails to exhibit effector activity or efficiently bind tetramers
incorporating the HA210-219 epitope.
Cultures of antigen-specific CD81 CTLs can be main-
tained and expanded by successive rounds of restimulation
with antigen at periodic intervals. To further evaluate if the
activated noncytolytic CD81 T cells in cultures stimulated
with the GV virus were specific for the subdominant
HA210-219 epitope, these cultures were subjected to two
further rounds of in vitro stimulation at 14-d intervals. At
Table I. Activated Lymphocytes in Bulk Cultures
Stimulus*
Percentage of
CD81 T cells AA GV B/Lee
HA-specific‡
(tetramer positive) 15.6 6.1 ,1
Activated phenotype
(CD44hiCD62Llo) 18.3 25.2 3.1
*Indicates strain of influenza virus used to infect antigen-presenting
cells for stimulation of splenocyte cultures dervied from rVV HA A2–
primed Balb/c mice. Values are the percentage of CD81 T cells ex-
pressing the indicated phenotype after viral antigenic stimulation.
‡HA-specific denotes cells that stained positive for HA204-212 tet-
ramer in the AA culture. For the B/Lee culture, 0.9% of CD8 T cells
stained positive for HA204-212 tetramer, and 0.8% of CD8 T cells
stained positive for HA210-219 tetramer.
Table II. Effector Activity of Virus- and Peptide-stimulated
Cultures
Cytolytic activity‡
Stimulus* 1:1 5:1 10:1
Percentage of
activated CD81 T cells
(CD44hiCD62Llo)§
GV virus 9 [7] 5 [0] 9 [8] 45
HA210-219
peptide (13) 6 [0] 1 [8] 7 [7] 61
HA210-219
peptide (mx) 49 [5] 60 [1] 75 [8] .95
*Indicates antigenic stimulus used to activate immune splenocytes from
primed BALB/c donors. Peptide-specific effectors were generated by
cocultivating immune splenocytes with irradiated splenocytes that had
been pulsed with 1029 M HA210-219 synthetic peptide and washed
twice before cocultivation. Analyses were carried out on day 5–6 after
the first in vitro stimulation of immune cells, except for the peptide
(multiple times [mx]) group, which had undergone eight rounds of in
vitro restimulation with synthetic peptide.
‡Values are the mean percentage of 51Cr release by the activated cells in
a 5-h assay carried out 5 d after in vitro culture with virus-infected or
peptide-pulsed APCs at the indicated E/T ratios on HA210-219–
pulsed P815 target cells. Mean lysis of untreated target cells at each ratio
are given in brackets.
§Indicates the percentage of CD81 T cells exhibiting an activated
(CD44hiCD62Llo) phenotype as determined by flow cytometry 6 d af-
ter the first in vitro stimulation of immune cells with antigen.
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day 5 after the second and third round of stimulation, via-
ble cells were examined for expression of CD8 and CD44
(or CD62L) and for staining with HA tetramer. Compan-
ion cultures of HA204-212–specific CD81 T cells were
expanded by restimulation with AA virus and were exam-
ined in parallel. As Fig. 4 (top) demonstrates, .90% of via-
ble cells after the second stimulation with the AA virus
were CD81 and bound the HA204 tetramer. This pheno-
type was maintained after the third round of in vitro stimu-
lation. Therefore, as expected, in vitro restimulation with
specific antigen enriched for these dominant HA204-212–
specific CD81 T cells in culture.
When cultures containing the subdominant HA210-
219–specific CTLs were restimulated with GV virus in
vitro, a distinctly different pattern of tetramer staining was
observed (Fig. 4, bottom). After the second round of
in vitro stimulation with HA210-219–expressing GV-
infected APCs, 90% of viable cells in the culture were
CD81, indicating the expected selective enrichment of an-
tigen-specific CD81 T cells after restimulation. Approxi-
mately 40% of the CD81 T cells stained positive for the
HA210 tetramer. However, after a second round of anti-
genic stimulation, 60% of the stimulated CD81 T cells re-
tained the tetramer-negative phenotype. After a third
round of stimulation, .90% of viable cells in these cultures
were CD81, with HA210 tetramer–binding cells now rep-
resenting z60% of the total cells. Despite the increased
frequency of HA210 tetramer–positive cells in these cul-
tures, activated CD81 HA210 tetramer–negative cells still
represented a substantial fraction (40%; Fig. 4) of the total
CD81 T cells in these cultures after three successive
rounds of in vitro stimulation. Expansion of the small
number (6.1%) of HA210 tetramer–positive cells in the
initial cultures could account for the progressive increase in
tetramer-staining cells after repeated exposure to HA210-
219–expressing GV-infected APCs. However, the contin-
ued presence of activated CD81 HA210 tetramer–negative
T cells in these cultures most likely reflects specific stimu-
lation and antigen-dependant proliferation of HA210-219–
specific cells that fail to interact with HA210 tetramer.
As HA210 tetramer–positive CD81 T cells represented
z50–60% of activated cells in tertiary GV-stimulated cul-
tures, it was of interest to determine if the cells in these
cultures now exhibited CD81 T cell effector activities.
Tertiary cultures containing HA210-219 and HA204-212–
specific CD81 T cells, described above, were analyzed for
cytolytic activity on peptide-pulsed target cells and for in-
tracellular IFN-g staining (Fig. 5). Tertiary cultures of AA-
stimulated HA204-219–specific CD81 T cells (Fig. 5 A)
and GV-stimulated HA210-219–specific CD81 T cells
(Fig. 5 B) both exhibited high levels of epitope-specific cy-
tolytic activity. Comparable results were obtained when
HA210-specific immune splenocytes underwent multiple
rounds of in vitro restimulation with the synthetic HA210-
219 peptide (Table II). Thus, after two or more rounds of
restimulation with antigen, the CD81 CTLs in the sub-
dominant cultures now displayed a level of specific cyto-
lytic effector activity comparable to that of the HA204-212–
specific CTLs present in the dominant cultures. Although
Figure 4. Effect of antigenic stimulation on tetramer staining by CD81
T cells. Immune splenocytes were stimulated once (13) in vitro with
A/AA/57-infected or GV-infected APCs to selectively activate HA204-
212–specific or HA210-219–specific CD81 T cells, respectively. Immune
cell cultures were successively restimulated twice (23, 33) at 14-d inter-
vals with homologous virus. 5 d after each in vitro stimulation, cells were
harvested and viable cells were stained with anti-CD8–CyChrome, HA
tetramer (TET) PE and either CD44-FITC or CD62L-FITC. HA204-
212 cultures were stained with HA204 tetramers, and HA210-219 cul-
tures were stained with HA210 tetramers. The values within each panel
are the percentage of total CD81 T cells that are tetramer positive and, in
parentheses, the percentage of total CD81 T cells with an activated phe-
notype (CD44hiCD62Llo). These results are representative of five inde-
pendent experiments.
Figure 5. Effector activity of
tertiary bulk cultures. 5 d after
the third in vitro stimulation with
homologous virus–infected APCs,
bulk cultures were analyzed for
cytolytic activity and IFN-g pro-
duction as described in the leg-
end to Fig. 3. A and C represent
activity of tertiary HA204-21–
specific AA virus–stimulated cul-
tures. B and D represent tertiary
HA210-219–specific GV virus–
stimulated cultures.
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the potent lytic activity of the subdominant CD81 T cell
population could be attributed to the 50–60% of CD81 T
cells that are HA210 tetramer positive, the analysis of intra-
cellular IFN-g staining did not support this view. As shown
in Fig. 5, C and D, z92% of the cells in AA-immune ter-
tiary cultures and 86% of the cells in GV-immune tertiary cul-
tures exhibit antigen-dependent IFN-g production. How-
ever, the presence of a high percentage of IFN-g–secreting
cells with potent lytic activity in the HA210-219–specific
culture suggested that both HA210 tetramer–positive and
–negative CD81 T cells contributed to the CTL effector
activity observed.
To directly evaluate this point, day 5 effectors from ter-
tiary GV-stimulated cultures were sorted by flow cytome-
try into HA210 tetramer–positive and –negative fractions.
The tetramer-positive and -negative fractions were tested
along with unfractionated cells for in vitro cytolytic activ-
ity. For technical reasons, we were unable to take sorted
HA210 tetramer–positive and –negative cells and simulta-
neously monitor tetramer binding and intracellular IFN-g
accumulations. So it was not possible to directly demon-
strate IFN-g production by the HA210-negative CD81 T
cells. As shown in Fig. 6, epitope-specific cytolytic activity
was demonstrable in both the tetramer-positive and -nega-
tive CD81 T cell populations. The diminished cytolytic
activity exhibited by the HA210 tetramer–positive cell
fraction may represent interference with T cell receptor
recognition events as a result of tetramer binding to these
cells or some loss of cell viability during the cell sorting
procedure. Nevertheless, these results demonstrate that ac-
tivated HA210 tetramer–negative CD81 T cells not only
can be expanded and propagated continuously in culture,
but also acquire antigen-specific effector activity after re-
peated antigenic stimulation. This includes both the devel-
opment of antigen-specific cytolytic activity and antigen-
dependent cytokine production.
The presence of subdominant HA210-219–specific
CTL effectors that failed to bind the HA210 tetramer was
unexpected. These tetramer-negative CD81 T cells were
detected in multiple independent experiments using sev-
eral different preparations of HA210 tetramers. The per-
centage of HA210 tetramer–positive and –negative cells in
GV-stimulated cultures was identical whether the staining
procedure was carried out at 48C or 378C, and remained
unchanged over a 30-fold concentration of HA210 tet-
ramer used in the staining procedure (data not shown).
One explanation for the failure of activated antigen-spe-
cific CD81 effector cells to bind the HA210 tetramer is
that the cells express a lower level of the TCR complex
than the tetramer-positive cells present in cultures of
HA210-219– or HA204-212–specific cells. To examine
this possibility, we analyzed the level of expression of the
TCR b chain, CD3, and CD8 present on effector cells in
cultures after tertiary stimulation with either AA virus
(.90% HA204 tetramer–positive cells) or GV virus (50–
60% HA210 tetramer–positive cells; Fig. 4). If subdomi-
nant HA210-219–specific CD81 effectors contained a
mixture of tetramer-positive TCRhi cells and tetramer-
negative TCRlo cells, then these cultures would exhibit ei-
ther a bimodal distribution of TCR complex staining or a
lower overall level of TCR complex expression. As shown
in Fig. 7, cultures of dominant HA204-212–specific CD81
CTLs and cultures of subdominant HA210-219–specific
CD81 CTLs expressed comparable levels of TCR b chain,
CD3, and CD8.
TCR Vb gene usage by dominant and subdominant
CD81 T cell populations was also determined by flow cy-
tometry after one or three rounds of in vitro stimulation.
Figure 6. Cytolytic activity of
sorted HA210 tetramer–positive
and tetramer-negative CTLs.
Bulk CTL populations, stimu-
lated three times in vitro with
GV virus–infected APCs, were
stained with HA210 tetramer–PE
and anti-CD8–FITC, then sorted
via FACS® into .99% pure tet-
ramer-positive and -negative
populations. Sorted populations,
as well as samples of the unsorted
bulk culture, were assayed for cy-
tolytic activity in a 51Cr-release
assay using P815 target cells
pulsed with 1029 M of the indi-
cated peptide (E/T 5 5:1). These
results are representative of three
independent experiments. Black bars, HA210 tetramer–positive cells;
white bars, HA210 tetramer–negative cells; hatched bars, unsorted tertiary
GV bulk culture.
Figure 7. Surface expression of TCR complex on dominant and sub-
dominant CTLs. 5 d after a third in vitro stimulation with virus-infected
APCs, dominant (HA204) and subdominant (HA210) bulk cultures
were stained with anti–TCR-b or anti-CD3 and anti-CD8 (solid histo-
grams) or with corresponding isotype control antibodies (open histo-
grams), as indicated.
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Not unexpectedly, both the HA204-specific and the HA210-
specific CD81 T cells were heterogeneous in terms of Vb
gene usage with TCR Vb2, 3, 6, 7, 8.1/8.2, 8.3, 10b, 13,
and 14 positive cells representing 4% or more of the acti-
vated CD81 cells. Representative percentages of Vb cells
for HA210 specific CD81 T cells after three rounds of in
vitro stimulation are: Vb2 [5.4]; Vb4 [6.2]; Vb6 [16.4]; Vb7
[5.0]; Vb8.1/8.2 [25.5]; Vb8.3 [12.4]; Vb10b [10.0]; Vb13
[4.2]; Vb14 [14.3], with values in brackets indicating the
percentage of activated CD81 cells expressing the indicated
Vb gene. We noted no significant difference in the range of Vb
gene usage displayed by HA210-specific tetramer-positive
and -negative cells. Much greater variability in the percent-
age of CD81 cells expressing specific Vb genes was evident
between individual HA210-specific donors in different ex-
periments.
An alternative explanation for the inability of these sub-
dominant CTL effectors to bind the HA210 tetramer is
that they represent a population of low-affinity CTLs with
TCRs that are capable of binding to peptide–MHC ligand
on the surface of infected APCs or peptide-pulsed target
cells, but they are unable to bind soluble MHC tetramers
with sufficient avidity to prevent tetramer dissociation.
Therefore, cultures of subdominant HA210-219–specific
CTLs may contain a mixture of high-affinity tetramer-pos-
itive CTLs and lower-affinity tetramer-negative CTLs,
whereas the cultures of dominant HA204-212–specific
CTLs consist exclusively of high-affinity tetramer-positive
CD81 effectors. To evaluate the relative affinity of domi-
nant and subdominant CTL populations, we examined the
peptide dose dependence of target cell lysis by HA204-
212– and HA210-219–specific cytolytic effectors present at
day 5 after tertiary stimulation with AA or GV virus. The
latter cultures consisted of z40% HA210 tetramer–nega-
tive CD81 T cells. As Fig. 8 demonstrates, both HA204-
212–specific and HA210-219–specific CTL effectors had
comparable peptide dose dependencies for target cell lysis,
with optimal cytolysis observed at 1029–10210 M peptide
concentrations. A comparable peptide dose dependence for
target cell recognition and lysis was obtained using HA210
tetramer–negative HA210-219–specific CD81 effectors se-
lected by cell sorting before use in the in vitro cytotoxicity
assay (Fig. 8 C), although both tetramer-positive and -neg-
ative CD81 cells exhibited lower lytic activity on a per cell
basis than the heterogeneous cell population before sorting.
The results in Fig. 8 indicated that the heterogeneous
population of tetramer-positive and -negative CD81 T
cells comprising the cultures of HA210-219 CTL effectors
had the same overall affinity as the uniform population of
tetramer-positive CTLs present in the HA204-212–spe-
cific cultures. Because HA210 tetramer–positive cells pro-
gressively accumulated upon repeated stimulation with the
GV virus (Fig. 4), we considered the possibility that, rather
than representing a distinct population of low-affinity ef-
fector T cells, the HA210 tetramer–negative CTL effectors
gave rise to HA210 tetramer–positive cells upon antigenic
stimulation.
To assess the precursor–product relationship between
tetramer-negative and tetramer-positive HA210-219–spe-
cific CD81 T cells, cell depletion experiments were carried
out. Immune cells consisting of a mixture of HA210 tet-
ramer–positive and –negative cells were harvested 14 d af-
ter the first in vitro stimulation with GV virus. The HA210
tetramer staining profile of this resting cell population be-
fore depletion is shown in Fig. 9 A. HA210 tetramer–bind-
ing cells were depleted from these cultured cells by mag-
netic bead separation. The remaining viable cells, which
consisted of .99% HA210 tetramer–negative T cells (Fig.
9 B), underwent a second round of in vitro stimulation
with GV-infected APCs. 5 d after stimulation, the cells
were evaluated for HA210 tetramer staining. As Fig. 9 C
demonstrates, both HA210 tetramer–positive and –nega-
tive CD81 T cells were detected in the culture. Tetramer-
positive cells represented z35% of the viable CD81 T cells
in culture. These results support the view that subdominant
tetramer-negative CD81 T cells can give rise to cells that
stain positive for HA210 tetramer after antigenic stimula-
tion. However, it is formally possible that the tetramer-
negative CD81 T cells did not undergo extensive prolifera-
tion, and that a small number of HA210 tetramer-positive
CD81 T cells contaminating the cell culture after magnetic
bead separation underwent preferential proliferative expan-
sion in response to antigenic stimulation.
To examine the proliferative potential of the HA210 tet-
ramer–negative cells, these day 14 cells, after magnetic bead
depletion, were labeled with the fluorescent dye CFSE be-
fore antigenic stimulation. This dye decreases proportion-
ately in fluorescence intensity with each cell division, al-
lowing for quantitation of cell divisions by flow cytometry
Figure 8. Peptide dose depen-
dence of dominant and subdomi-
nant CTLs. On day five or six af-
ter tertiary in vitro stimulation
with virus-infected APCs, cy-
tolytic activity was examined on
peptide-pulsed targets over the
indicated peptide concentrations
as described. (A) AA-stimulated
cultures tested on HA204-212
peptide–pulsed P815 target cells.
(B) GV-stimulated cultures tested
on HA210-219 peptide–pulsed
P815 target cells. (C) FACS®-
sorted HA210 tetramer–positive
(h), tetramer-negative (x), and
unsorted (j) CD81 T cells from
tertiary stimulated GV cultures
tested on HA210-219–pulsed
targets. Assay time was 5 h at an
E/T ratio of 10:1. Values are the
mean percentage of lysis of qua-
druplicate samples. SE values
were #3% of mean values and
are not shown. “0” indicates tar-
get cells not treated with peptide,
and “529” indicates target cells
treated with 1028 M concentra-
tion of the irrelevant HA529
synthetic peptide.
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(29). At the time of in vitro stimulation with GV-infected
APCs, the HA210 tetramer–negative cells showed a uni-
form pattern of high-intensity CFSE staining (Fig. 10 A). 5 d
after in vitro antigenic stimulation, viable cells were eval-
uated for CFSE staining intensity and HA210 tetramer
binding. As Fig. 10 B illustrates, CFSE-stained cells fell into
two distinct distributions. A large fraction of cells (R1)
stained weakly for the dye, indicating a population of cells
that had undergone five or more cell divisions in response
to antigenic stimulation. When this population of recently
dividing CD81 T cells was examined for HA210 tetramer
staining, tetramer-positive and tetramer-negative cells were
equally represented (Fig. 10 C). These data indicate that
HA210 tetramer–negative precursor cells proliferate in re-
sponse to antigen and give rise to both tetramer-positive
and tetramer-negative cells. By contrast, the second cell
fraction (R2) stained strongly for CFSE, indicating a popu-
lation of cells that had undergone only a limited number of
cell divisions. Analysis of CD8 expression and HA210 tet-
ramer staining by this population revealed that all cells in
this fraction were tetramer negative and primarily CD8
negative (Fig. 10 D). These residual nondividing cells in
the cultures are probably not antigen specific.
Discussion
In this report, we have used MHC class I tetramer stain-
ing and activation marker expression to examine the mem-
ory murine CTL response in the spleen to a dominant
(HA204-212) and a subdominant (HA210-219) epitope of
the HA protein. We found that the frequency of subdom-
inant HA210-specific cells responding to antigen was
higher than predicted from the cytolytic activity, cytokine
release, or MHC class I tetramer staining of the responding
CD81 T cells. A large number of immune CD81 T cells
proliferated in response to the HA210-219 epitope and
displayed an activated phenotype, but the majority of these
cells did not express effector activity as measured by in
vitro cytolysis assay or intracellular IFN-g staining. Unex-
pectedly, these antigen-reactive cells also failed to bind
HA210 tetramer. However, upon repeated exposure to
antigen, these subdominant CD81 T cells gained effector
activity and ultimately switched from a tetramer-negative
to a tetramer-positive phenotype. These results suggest a
novel mechanism for the occurrence of subdominant or
weak CTL responses at the level of CD81 T cell activation
and differentiation.
The weak response to the subdominant HA210 epitope
is not an exclusive property of memory CTL precursors in
the spleen undergoing activation in vitro. The weak re-
sponse of CD81 T cells to the HA210 epitope is also ob-
served in the lungs of mice undergoing primary pulmonary
infection with A/Japan/57 virus (Lawrence, C.W., and
T.J. Braciale, unpublished observations). This unusual
property of HA210-specific CD81 T cells is not readily at-
tributable to the use of the GV influenza strain as the im-
munogen for in vitro stimulation, because immune spleno-
cytes stimulated with a synthetic peptide corresponding to
the HA210-219 epitope give rise to effector cells with a
Figure 9. Generation of HA210 tet-
ramer–positive CD81 cells from HA210
tetramer–negative cells in response to anti-
gen. Freshly isolated immune splenocytes
were stimulated one time in vitro with
GV-infected APCs. At day 14 after stimula-
tion, the residual viable cells were incu-
bated with a 10-fold excess of PE-labeled
HA210 tetramer, washed, and incubated
with anti-PE antibody–coated magnetic
microbeads. Tetramer-binding cells were
depleted from the culture by magnetic cell
separation. The column flow-through
(CD81, HA210 tetramer–negative cells) was washed and then restimulated by coculture with GV-infected APCs. 5 d after stimulation, viable cells were
harvested and stained with CD8-perCP and HA210 tetramer–PE, then examined by flow cytometry. (A) Resting GV cultures on day 14 (13 GV d14).
(B) Tetramer-negative column flow-through cells before stimulation (HA210 tet1 depleted). (C) Composition of cultures 5 d after stimulation of
flow-through cells (23 GV d5).
Figure 10. Proliferation of separated HA210 tetramer-negative cells af-
ter antigenic stimulation. Tetramer-negative cells were isolated as de-
scribed in the legend to Fig. 9. Before antigenic stimulation, cells were la-
beled with the CFSE dye to monitor cell division. (A) CFSE fluorescence
intensity of freshly labeled cells. (B) Dye intensity of CFSE-labeled cells at
day 5 after stimulation with GV-infected APCs. (C and D) HA210 tet-
ramer and CD8 staining of day 5 cells in dye peak R1 (C) and R2 (D).
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similar phenotype as immune cells stimulated with virus-
infected APCs (Table II; Spencer, J.V. and T.J. Braciale,
unpublished observations). Our results strongly suggest that
the subdominant response to the HA210 epitope is not due
to a low frequency of antigen-specific CD81 T cells, but
rather to the inability of the majority of HA210-specific
memory CTL precursors to fully differentiate into activated
CTL effectors after initial exposure to the viral antigen.
Full expression of effector activity requires subsequent
rounds of antigenic stimulation and further cell division to
complete the differentiation process.
Selective induction of specific effector activities has been
reported in the response of fully differentiated CD81 CTL
effectors to antigen. Valitutti et al. (33) demonstrated that
the expression of cytolytic activity by human CD81 CTL
clones could be elicited at low peptide concentrations by
engagement of a very small number of T cell receptors (33).
Only at increasing levels of TCR occupancy were prolifer-
ation and production of IFN-g observed. Selective expres-
sion of cytolytic activity to an antigenic stimulus by CD81
CTLs in the absence of other effector responses has also
been reported in other systems (34, 35). Much less informa-
tion is available concerning the antigen-driven transition of
CD81 T cells from the resting state into activated CTL ef-
fectors. Although CD81 T cell responses ranging from an-
ergy to exhaustion have been observed, in only one report
dealing with the response of H-Y–specific TCR transgenic
CD81 T cells to the male antigen has antigen-specific pro-
liferation of resting, naive CD81 T cells without the ex-
pression of cytolytic activity been observed (36). The results
reported here suggest that a heterogeneous population of
memory CD81 T cells directed to a viral epitope can acti-
vate and proliferate in response to antigen without fully dif-
ferentiating into armed CD81 T cell effectors.
Memory CD81 T cells directed to the dominant
HA204-212 epitope and the subdominant HA210-219
epitope, although apparently comparable in frequency, dif-
fer dramatically in their response to viral antigen. Dominant
CD81 T cells fully differentiate into effector CTLs in re-
sponse to the viral agonist, whereas subdominant CD81 T
cells appear to activate, but not fully differentiate. One ex-
planation for the incomplete differentiation of the T cells
directed to the HA210 epitope is that these CD81 T cells
are in an altered activation state before initial contact with
the agonist HA210 epitope. A mechanism that may account
for this altered activation state of the subdominant CD81 T
cells is suggested by our earlier observation that CD81
CTLs directed to the HA210 epitope exhibit cross-reactive
recognition of a self-IgVH–derived peptide. This self-pep-
tide acts as a partial agonist/antagonist ligand capable of
stimulating a subset of CTL effector activities from mature
CD81 CTL effectors (19). It is possible that contact with
this and/or other self-peptides in vivo before virus infection
partially antagonizes the HA210-219–specific CD81 T
cells, rendering the antagonized cells unable to fully differ-
entiate upon subsequent encounters with the HA210-219
agonist ligand. Interference with normal T cell activation/
differentiation is a well-recognized consequence of T cell
interaction with altered peptide ligands that exhibit partial
agonist or antagonist properties (37, 38). Preliminary studies
in which HA210-specific memory CD81 T cells have been
stimulated in short-term culture in the absence of B lym-
phocytes have not demonstrated the rapid conversion of
the majority of responding subdominant T cells from a tet-
ramer-negative noncytolytic phenotype to the tetramer-
positive cytolytic phenotype exhibited by the dominant
HA204-specific CTLs. Whether this result is due to our in-
ability to completely eliminate B lymphocytes during prim-
ing in vivo and restimulation in vitro, or whether this result
indicates that other self-antigens not displayed on B lym-
phocytes alter the activation state of the HA210-specific
CD81 T cells is currently under investigation.
An unexpected finding in this analysis was the observa-
tion that the majority of CD81 T cells responding to
HA210-219 do not bind the HA210 tetramer after initial
proliferation in response to antigen. HA210 tetramer–posi-
tive cells increasingly accumulate only after restimulation of
activated CD81 T cells by the subdominant HA210-219
epitope. This unusual phenotype was not exhibited by
CD81 T cells directed to the dominant HA204-212
epitope, where there was a direct correspondence among
antigen-driven T cell activation, the expression of effector
activity, and HA204 tetramer binding. The observation
that tetramer-negative HA210-reactive T cells displayed
cell surface TCR, CD3, and CD8 at levels comparable to
that of the tetramer-positive HA204-reactive cells argues
against antigen-induced TCR downmodulation (39, 40) as
a likely explanation for this phenotype. Although differ-
ences in TCR avidity have been detected based on the rate
of tetramer dissociation (41), the tetramer-negative HA210-
219–specific CD81 T cells did not appear to represent a
distinct subpopulation of T cells with low-avidity TCRs.
We noted no difference in the peptide dose dependence of
target cell recognition between tetramer-positive and -neg-
ative CTL effector cells. More importantly, when purified
HA210 tetramer–negative CD81 T cells were stimulated
by antigen, they gave rise to daughter cells that exhibited a
tetramer-positive phenotype. This finding strongly suggests
that tetramer-negative T cells are the precursors of tetra-
mer-positive T cells, and that this transition requires anti-
genic stimulation. In support of this idea, we have found in
preliminary studies that exposure of tetramer-negative
CD81 T cells to a strong mitogenic stimulus rapidly con-
verts the cells from a tetramer-negative to a tetramer-posi-
tive phenotype within 12–18 h. In addition, after multiple
cycles of in vitro restimulation with antigen, all HA210-
specific CD81 T cells present in long-term cultures are tet-
ramer positive.
The conversion of tetramer-negative CTLs to a tet-
ramer-positive phenotype in response to antigen could re-
flect a change in TCR conformation, rendering the recep-
tors displayed by CTLs capable of efficiently binding the
soluble tetramer. Alternatively, the TCRs on tetramer-
negative CD81 T cells could be arrayed on the cell surface
in a manner unfavorable for efficient tetramer binding.
Upon subsequent exposure to antigen, the TCRs on these
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cells would then undergo activation-dependent redistribu-
tion to form a cell surface array more favorable to efficient
tetramer binding. The recent reports of the asymmetric dis-
play of TCR-associated signaling molecules on cell surfaces
in sequestered membrane domains (42, 43) suggest possible
mechanisms to explain the inability of the TCR to effi-
ciently bind tetramers. Why this tetramer-negative pheno-
type is associated only with HA210-reactive CD81 T cells
is not clear. It is possible that prior exposure to partial ago-
nist/antagonist self-peptides in vivo triggers the re-distribu-
tion of TCRs on these subdominant T cells into a cell
surface array unfavorable to efficient tetramer binding.
Nevertheless, the CD81 cells must be still capable of en-
gaging HA210-219 peptide–MHC complexes on infected
cell surfaces. Only after repeated stimulation by the agonist
HA210-219 epitope do the TCRs on these cells redistrib-
ute into a cell surface array allowing MHC tetramers to ir-
reversibly bind the TCR.
The observations reported here indicate that the sub-
dominant or weak CD81 CTL response to the HA210-219
epitope is not due to a low frequency of memory CTL pre-
cursors, but is instead due to the inability of the majority of
CTL precursors to efficiently differentiate into effector
CTLs after antigenic stimulation. Memory CD81 T cells to
this epitope proliferate in response to antigen and acquire
cell surface markers of activated T cells, but they do not ex-
hibit effector activity (i.e., IFN-g secretion or cell-medi-
ated cytotoxicity) and fail to bind MHC tetramers. With
repeat antigenic stimulation, these CD81 T cells transition
first to tetramer-negative cells with full effector function,
and then to tetramer-positive CTL effector cells. These
findings provide a potential explanation for the higher fre-
quency of antigen-specific CD81 effectors as defined by in-
tracellular cytokine staining rather than by tetramer bind-
ing, as recently reported in experimental palmy virus
infection (44). More importantly, these data suggest that
repeated vaccination may not only expand the pool of
memory CD81 T cells directed to viral antigens, but may
also drive memory CD81 T cells into a state of differentia-
tion where cells with full effector potential are rapidly gen-
erated in response to viral infection. At present, we do not
know whether this altered activation and delayed differen-
tiation is a feature of other subdominant CD81 CTL re-
sponses. Our results do suggest that along with control at
the level of antigen processing and presentation and anti-
genic competition (11, 45), the ability of CD81 T cells to
differentiate into effector cells may be critical in regulating
the CTL response to foreign antigen.
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